Can Giant Cell Tumor of the Bone Occur in the Skeletally Immature?

2020 ◽  
Vol 110 (2) ◽  
Author(s):  
Amber Haseeb ◽  
Vivek Ajit Singh ◽  
Pailoor Jayalakshmi

Giant cell tumor (GCT) of the bone is a benign, locally aggressive neoplasm that has a high tendency for local recurrence. It usually has a higher incidence in the third decade of life. This is a retrospective review of a case with histologic confirmation of GCT in a skeletally immature patient involving the metatarsal bone, which is a rare site. At our institution, 1.3% of skeletally immature patients had GCT of the bone. From an extensive literature review, only four cases of GCT of the metatarsal bone in the skeletally immature were identified. Giant cell tumor in a skeletally immature patient can be confused for an aneurysmal bone cyst because of similar radiologic findings. Giant cell tumor of the bone can occur in an immature skeleton and should be sought out as a differential diagnosis despite being rare.

2020 ◽  
Vol 77 ◽  
pp. 560-564
Author(s):  
Manuel A. Ramírez-González ◽  
Gerardo Olivella ◽  
Norman Ramírez ◽  
Antonio Soler-Salas ◽  
Eric Astacio ◽  
...  

2021 ◽  
Author(s):  
taojun gong ◽  
Yi Luo ◽  
Yitian Wang ◽  
Chuanxi Zheng ◽  
Jianguo Fang ◽  
...  

Abstract Background: Giant cell tumor of bone (GCTB) is a rare benign but locally aggressive bone tumor. It has a high tendency for local recurrence, which may increase the occurrence of lung metastasis. Currently, the treatment of pulmonary metastases of GCTB is controversial. Denosumab is the preferred regimen for unresectable metastatic lesions, but there are no alternative treatment options when denosumab is resistant. So far, no case reports of metastatic GCTB treated with denosumab and apatinib have been published. Case presentation: This is a case report of a 26-year-old female who experienced right knee pain for over 6 months. Radiography and computed tomography revealed osteolytic bony destruction in the proximal right tibia. Using histological, radiological, and clinical techniques, a diagnosis of GCTB was achieved. Meanwhile, the immunohistochemical stain-identified the tumor cells were positive for vascular endothelial growth factor receptor 2 (VEGFR-2). After intralesional curettage of the primary tumor and wide resection of local recurrence surgeries, she developed recurrent hemoptysis. Chest computed tomography (CT) images showed multiple pulmonary nodules. She was administrated denosumab therapy but disease progression was confirmed after four months of treatment. She then received denosumab and apatinib therapy for 24 months, after a partial response was achieved.Conclusions: We depict a case of multiple pulmonary metastases of GCTB successfully controlled by denosumab and apatinib therapy. VEGFR-2 may be an effective therapeutic target for GCTB with pulmonary metastasis when denosumab is ineffective.


2016 ◽  
Vol 32 (5) ◽  
pp. 873-876 ◽  
Author(s):  
Loic Sigwalt ◽  
Emeline Bourgeois ◽  
Ahmad Eid ◽  
Chantal Durand ◽  
Jacques Griffet ◽  
...  

2016 ◽  
Vol 11 (6) ◽  
pp. 4045-4048 ◽  
Author(s):  
MINGZHI SONG ◽  
WEI DAI ◽  
RAN SUN ◽  
HONGFENG LIANG ◽  
BINGWU LIU ◽  
...  

2016 ◽  
Vol 51 (5) ◽  
pp. 411
Author(s):  
Hyung Min Lee ◽  
Se Kyung Park ◽  
En Mi Cho ◽  
Sun Ju Oh ◽  
So Hak Chung

1997 ◽  
Vol 17 (2) ◽  
pp. 276
Author(s):  
R. Casadei ◽  
P. Ruggieri ◽  
M. Moscato, et al.

1991 ◽  
Vol 6 (1) ◽  
pp. 69 ◽  
Author(s):  
Yong Koo Park ◽  
Kyung Nam Ryu ◽  
Chung Soo Han ◽  
Youn Wha Kim ◽  
Moon Ho Yang

Sign in / Sign up

Export Citation Format

Share Document